Page 82 - Lipids News Today

While obesity often puts people at risk for numerous diseases, geneticists from the University of Exeter say the overriding predictor of whether someone will develop these issues are their genes.

Inclisiran, a novel small interfering RNA drug that inhibits PCSK9, made its US debut in early 2022 with cautious uptake prospects.

Young women may be at a higher risk of ischemic stroke than young men, a new systematic review shows, representing a significant departure from our current scientific understanding, researchers say.

An international research team has established a link between gut microbiota and chronic inflammatory diseases such as arthritis.

Retinal age gap, defined as age predicted from the fundus image minus chronologic age, is associated with the arterial stiffness index and may be a novel biomarker for subclinical CVD.

A study recently identified Neurolipin-1 or NRP1, a host factor for SARS-CoV-2 infection, as a cargo retrograde-transported by the ESCPE-1.

They’re old, but not dead; retired, but not tired; aging, but still dreaming, and now they have spoken.

Scientists report that they have built a living "minimal cell" with a genome stripped down to its barest essentials – and a computer model of the cell that mirrors its behavior. By refining and testing their model, the scientists say they are developing a system for predicting how changes to the genomes, living conditions or physical characteristics of live cells will alter how they function.

Elevated blood markers for neurodegeneration can better predict risk of dementia when markers for cerebrovascular disease are also elevated. A link between vascular health and mental health has been found.

Use of medications to manage cardiovascular disease risk factors significantly decreased during the COVID-19 pandemic in the UK and has not returned to prepandemic levels, a new study shows.